4 completed. 3 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow resminostat: new trials by email Literature Review of resminostat trials Research Report on resminostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab and RASi in Patients with IgAN Rituximab, RAS 2410 - IgA Nephropathy | Phase 4 | Completed | Nan Chen,MD | 116 | 2020-07-01 | 2025-03-14 |
| Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) resminostat, Placebo - Mycosis Fungoides, Sezary Syndrome | Phase 2 | Completed | 4SC AG | 201 | 2016-11-01 | 2024-08-30 |
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) Resminostat, Sorafenib - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Yakult Honsha Co., LTD | 179 | 2013-04-01 | 2018-01-16 |
| Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma Resminostat (4SC-201) - Hodgkin's Lymphoma | Phase 2 | Completed | 4SC AG | 37 | 2009-12-01 | 2014-01-16 |
Carcinoma, Hepatocellular (1) · Glomerulonephritis, IGA (1) · Hodgkin Disease (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1) · Proteinuria (1) · Sezary Syndrome (1)
4SC AG (2) · Nan Chen,MD (1) · Yakult Honsha Co., LTD (1)
Japan (2) · Poland (2) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Greece (1) · Italy (1) · Netherlands (1) · Romania (1) · South Korea (1) · Spain (1) · Switzerland (1)
Jan Walewski, Prof. (1) · Jingyuan Xie (1) · Rudolf Stadler, Prof. (1)
PMID 32632956, PMID 38299639, PMID 41651641
2016 (1)